What sits inside revenue per contract
Cboe's options business recorded 14% growth in average daily contract volume and a 9% increase in revenue per contract. Net revenue grew 23%. At first glance, volume and price appear to be rising comfortably together. The line that makes me pause is revenue per contract within index options: it rose only 3%. Index volume grew 24%, compared with 10% for multiply listed options. The company identifies a larger contribution from higher-revenue index products. The overall 9% increase also contains a change in what was sold.[1]
That distinction narrows the claim that can be made about pricing power. Earning more on the same product and selling more of a higher-revenue product are two earnings channels whose persistence depends on different conditions. Cboe's disclosure shows that the second channel also operated. A temporary concentration of demand in index options is an alternative to durable pricing power. The decline in total options market share from 30.9% to 30.5% also complicates any attempt to equate revenue growth with broader market-share gains.[1]
Adding the divestiture gain
There are two calculations on the way to operating profit. Net revenue was $712.2 million and reported operating expenses were $249.4 million. Adding the $71.5 million gain from selling the Australian business brings reported operating income to $534.3 million. That calculation produces a 75.0% margin. On an adjusted basis, $204.0 million of expenses is subtracted from $712.2 million of net revenue, leaving $508.2 million and a 71.4% margin. Each calculation is internally consistent, but they contain different earnings components.[1]
The rise in adjusted margin from 65.3% to 71.4% shows operating improvement even with the divestiture gain separated out. Net revenue growth of 18% alongside a 3% decline in adjusted expenses explains operating leverage under that definition. Reported expenses, however, increased 6%. The company mainly attributed that increase to a $14.0 million incremental reserve on notes receivable related to financing the Consolidated Audit Trail transaction recording system. I therefore read the adjusted expense decline as a measure with a specific perimeter. An alternative interpretation is that the scope of adjustments and the timing of expenses make the improvement appear more persistent than it is. Persistence depends partly on which expenses recur.[1]
The model’s sensitive input
Management lowered annual adjusted expense guidance from 838–853 million dollars to 830–845 million dollars. Capital expenditure guidance remained 98–108 million dollars. Those disclosures track different categories: a lower operating expense range does not establish a corresponding change in capital spending. Equally, the $508.2 million of adjusted operating income cannot be used as a free cash flow figure. My narrow reading of this quarter is that revenue mix and adjusted expense restraint jointly supported the operating margin.[1]
For shareholders, the sensitive assumption is the combination of a sustained weight of higher-revenue index products and the expense base. Extending the exclusive S&P index licence through 2051 lengthens contractual access to those products; it does not fix customers' trading intensity. A shift toward lower-revenue products or renewed expense growth are alternative conditions that weaken an earnings calculation anchored to this quarter's margin. The observable inputs include revenue per contract within index options, product weights and the gap between reported and adjusted expenses, alongside overall revenue per contract. Those components carry the burden of any claim about persistence.[1]